| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |